🔗 Permalink

Inventor profile of:

Jianhe Chen

City:

Beijing

Country:

China

Published Applications:

Last publication date:

2026-06-04

Top Assignees for applications by Jianhe Chen

The entities that hold a legal rights for patent applications filed by inventor Chen Jianhe:

Novo Nordisk A/S 5 Bagsvaerd, Denmark
NOVO NORDISK HEALTHCARE A/G 1 Zurich, Switzerland
NATIONAL INSTITUTE OF BIOLOGICAL SCIENCES, BEIJING 1 Beijing, China
NEWISH TECHNOLOGY (BEIJING) CO., LTD. 1 Beijing, China
Beijing Jingyuan Yangeng Biotechnologies Co., Ltd. 1 Beijing, China

Recent patent applications by Chen Jianhe

Jianhe Chen from Beijing, CN has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2026-06-04

US20260152555A1

Chemistry; metallurgy

ANTI-CD112R ANTIBODIES AND USE THEREOF

#2 | 2025-01-09

US20250011468A1

Chemistry; metallurgy

Procoagulant Antibodies

#3 | 2023-11-02

US20230348880A1

Chemistry; metallurgy

SOLUBLE ACE2 AND FUSION PROTEIN, AND APPLICATIONS THEREOF

#4 | 2023-02-23

US20230058721A1

Chemistry; metallurgy

Procoagulant Antibodies

#5 | 2021-12-16

US20210388114A1

Chemistry; metallurgy

Procoagulant antibodies

#6 | 2021-08-05

US20210238306A1

Chemistry; metallurgy

Procoagulant antibodies

#7 | 2020-12-31

US20200407409A1

Chemistry; metallurgy

EGF(A) ANALOGUES WITH FATTY ACID SUBSTITUENTS

#8 | 2019-01-17

US20190016768A1

Chemistry; metallurgy

EGF(A) analogues with fatty acid substituents

#9 | 2014-11-20

US20140341896A1

Chemistry; metallurgy

Humanized anti-human NKG2A monoclonal antibody

#10 | 2014-09-25

US20140287930A1

Chemistry; metallurgy

Sub-totipotent stem cell product and apparent hereditary modifying label thereof

#11 | 2013-02-14

US20130040883A1

Human necessities

Stable growth hormone compounds resistant to proteolytic degradation

#12 | 2011-03-03

US20110052606A1

Chemistry; metallurgy

Humanized anti-human NKG2A monoclonal antibody

InventorID:

91489 ⎘